Diana Ernst, RPh, Author at Medical Bag

Diana Ernst, RPh

All articles by Diana Ernst, RPh

Evenity Approved to Treat Osteoporosis in Postmenopausal Women at High Risk for Fracture

The Food and Drug Administration (FDA) has approved Evenity (romosozumab-aqqg; Amgen) injection for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapies.

Next post in Medicine